You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

IOPAMIDOL-200 IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Iopamidol-200 In Plastic Container patents expire, and when can generic versions of Iopamidol-200 In Plastic Container launch?

Iopamidol-200 In Plastic Container is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in IOPAMIDOL-200 IN PLASTIC CONTAINER is iopamidol. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iopamidol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Iopamidol-200 In Plastic Container

A generic version of IOPAMIDOL-200 IN PLASTIC CONTAINER was approved as iopamidol by HAINAN POLY on February 27th, 2023.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for IOPAMIDOL-200 IN PLASTIC CONTAINER?
  • What are the global sales for IOPAMIDOL-200 IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for IOPAMIDOL-200 IN PLASTIC CONTAINER?
Summary for IOPAMIDOL-200 IN PLASTIC CONTAINER
Drug patent expirations by year for IOPAMIDOL-200 IN PLASTIC CONTAINER
Recent Clinical Trials for IOPAMIDOL-200 IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chongqing Emergency Medical CenterN/A
Army Medical Center of PLAN/A
M.D. Anderson Cancer CenterN/A

See all IOPAMIDOL-200 IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for IOPAMIDOL-200 IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira IOPAMIDOL-200 IN PLASTIC CONTAINER iopamidol INJECTABLE;INJECTION 074636-001 Dec 30, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.